Mass Tort brief
Jerusalem Court Ends Samsung GOS Suit as Teva Faces US Mass Litigation
Jerusalem judges close the final global class action against Samsung while Teva Pharmaceuticals faces consolidated federal multidistrict litigation in Georgia.
Mass Tort
Consolidating Teva's generic drug injury claims into federal MDL streamlines defense overhead — setting up structured pre-trial frameworks for eventual multi-state settlements.
BackgroundMultidistrict litigation transfers complex product liability cases from federal courts nationwide to a single judge for unified pre-trial proceedings. Israeli generic drugmaker Teva faces ongoing US litigation involving generic drug price-fixing and product liability claims.
- Georgia federal court orders established unified electronic service guidelines for incoming personal injury claims against Teva USA.
- Concurrently, State Attorneys General are finalizing multi-state class action notice procedures for generic prescription pricing settlements.
- Consolidating pre-trial proceedings cuts defense overhead for Teva while establishing structured frameworks for eventual mass settlement negotiations.
Mass Tort
Samsung defeated four years of global GOS throttling claims with zero damages — Jerusalem's final withdrawal clears the phone maker's last remaining class action exposure.
BackgroundSamsung pre-installed Game Optimizing Service software on its Galaxy smartphones to prevent processor overheating during intensive mobile gaming. Consumers alleged the software secretly throttled device performance, misrepresenting hardware capabilities.
- The Jerusalem court order concludes a multi-jurisdictional legal battle across Israel, the United States, and South Korea.
- Israeli plaintiffs agreed to withdraw their petition after parallel litigation in South Korean and American courts collapsed without liability findings.
- Closing the final Israeli case removes Samsung's last remaining global class action exposure surrounding GOS performance management.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
